AGRX Annual ROE
88.64%
-369.65%-80.66%
31 December 2023
Summary:
As of February 4, 2025, AGRX annual return on equity is 88.64%, with the most recent change of -369.65% (-80.66%) on December 31, 2023. During the last 3 years, it has risen by +197.72% (+181.26%).AGRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGRX Quarterly ROE
104.04%
+43.12%+70.78%
01 June 2024
Summary:
As of February 4, 2025, AGRX quarterly return on equity is 104.04%, with the most recent change of +43.12% (+70.78%) on June 1, 2024. Over the past year, it has dropped by -261.79% (-71.56%).AGRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGRX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -80.7% | -71.6% |
| 3 y3 years | +181.3% | +167.1% |
| 5 y5 years | +190.4% | +250.4% |
AGRX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -80.7% | -93.2% |
Agile Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | 104.04%(+70.8%) |
| Mar 2024 | - | 60.92%(-47.1%) |
| Dec 2023 | 88.64%(-80.7%) | 115.09%(-18.4%) |
| Sept 2023 | - | 141.01%(-61.5%) |
| June 2023 | - | 365.83%(-76.3%) |
| Mar 2023 | - | 1541.06%(-230.9%) |
| Dec 2022 | 458.29%(-271.7%) | -1177.45%(+55.1%) |
| Sept 2022 | - | -759.02%(+32.8%) |
| June 2022 | - | -571.52%(+36.8%) |
| Mar 2022 | - | -417.68%(+45.3%) |
| Dec 2021 | -266.95%(+144.7%) | -287.52%(+54.5%) |
| Sept 2021 | - | -186.11%(+20.0%) |
| June 2021 | - | -155.11%(+46.8%) |
| Mar 2021 | - | -105.66%(+46.1%) |
| Dec 2020 | -109.08%(+168.2%) | -72.30%(+27.2%) |
| Sept 2020 | - | -56.84%(+21.3%) |
| June 2020 | - | -46.84%(+2.7%) |
| Mar 2020 | - | -45.62%(-23.1%) |
| Dec 2019 | -40.67%(-58.5%) | -59.36%(-9.7%) |
| Sept 2019 | - | -65.71%(-5.0%) |
| June 2019 | - | -69.19%(-7.4%) |
| Mar 2019 | - | -74.74%(-5.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | -98.04%(+25.8%) | -78.94%(+3.4%) |
| Sept 2018 | - | -76.34%(+0.8%) |
| June 2018 | - | -75.75%(-5.6%) |
| Mar 2018 | - | -80.27%(+1.1%) |
| Dec 2017 | -77.92%(+14.7%) | -79.37%(+8.1%) |
| Sept 2017 | - | -73.39%(+0.8%) |
| June 2017 | - | -72.78%(+12.0%) |
| Mar 2017 | - | -65.00%(+15.0%) |
| Dec 2016 | -67.96%(-33.4%) | -56.51%(-1.7%) |
| Sept 2016 | - | -57.49%(-12.4%) |
| June 2016 | - | -65.64%(-7.2%) |
| Mar 2016 | - | -70.73%(-11.1%) |
| Dec 2015 | -101.99%(+128.4%) | -79.60%(-5.1%) |
| Sept 2015 | - | -83.88%(+16.8%) |
| June 2015 | - | -71.82%(+23.8%) |
| Mar 2015 | - | -58.02%(-49.1%) |
| Dec 2014 | -44.65%(-322.7%) | -113.95%(-224.8%) |
| Sept 2014 | - | 91.32%(+216.4%) |
| June 2014 | - | 28.86%(+130.1%) |
| Mar 2014 | - | 12.54%(-37.5%) |
| Dec 2013 | 20.05%(-49.5%) | 20.06% |
| Dec 2012 | 39.69% | - |
FAQ
- What is Agile Therapeutics annual return on equity?
- What is the all time high annual ROE for Agile Therapeutics?
- What is Agile Therapeutics annual ROE year-on-year change?
- What is Agile Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Agile Therapeutics?
- What is Agile Therapeutics quarterly ROE year-on-year change?
What is Agile Therapeutics annual return on equity?
The current annual ROE of AGRX is 88.64%
What is the all time high annual ROE for Agile Therapeutics?
Agile Therapeutics all-time high annual return on equity is 458.29%
What is Agile Therapeutics annual ROE year-on-year change?
Over the past year, AGRX annual return on equity has changed by -369.65% (-80.66%)
What is Agile Therapeutics quarterly return on equity?
The current quarterly ROE of AGRX is 104.04%
What is the all time high quarterly ROE for Agile Therapeutics?
Agile Therapeutics all-time high quarterly return on equity is 1541.06%
What is Agile Therapeutics quarterly ROE year-on-year change?
Over the past year, AGRX quarterly return on equity has changed by -261.79% (-71.56%)